STAT Plus: A pioneer in cancer immunotherapy sees a future where vaccines, CAR-T, and checkpoint inhibitors come together
THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
A pioneer in studying pre-surgical use of immune checkpoint therapies shared her vision of the future for cancer treatment.
No hay comentarios:
Publicar un comentario